StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Well that CC was a glorious stunning bit of

<< Previous

Bullboard Posts

Next >>

Comment by Imhotep1on May 21, 2024 8:52am

88 Views

Post# 36049613

RE:Well that CC was a glorious stunning bit of

Honestly, has Tripp even delivered what he promised once? The only thing he has made sure of is having a big salary coming from the money raised from the financing offers he has made on multiple occasions. The guy has always cared about his personal well-being over investors.

An undeniable fact, He has lost nothing from the dizzying drop in price per share.

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?